top-banner

PHARMACOGENETICS

Determining an individual’s drug response to tailor medical treatment

OVERVIEW

Pharmacogenetics examines how a person’s genetic makeup can affect their response to medication, and predict whether they may experience side effects, like adverse drug reaction (ADR). ADR or therapy resistance can result from individual genetic differences in the genes coding for transporter proteins, enzymes, or drug targets. Variants in the corresponding genes can lead to altered metabolic rates (see figure) and impaired transport or binding capacity which can eventually lead to altered drug efficacy and tolerability.

Pharmacogenetic testing can identify these variants and the results can improve the safety and effectiveness of drug therapy by tailoring treatment to a person’s specific genetic profile and optimizing their drug dosage and care.

IMPORTANCE OF GETTING TESTED

Pharmacogenetics can help identify genetic factors that may affect a person’s response to a particular drug, thereby, enabling the determination of the most appropriate medication and dosage. This can be especially important for people with negative experiences with medications in the past or who are at higher risk for certain side effects.

It is important to note that, in some cases, the results of a pharmacogenetic test may not change treatment recommendations. We offer pharmacogenetic consultation to discuss potential benefits and limitations of testing.

WHO COULD BENEFIT FROM THIS TEST

top-banner

Patients with conspicuous findings in therapeutic drug monitoring

top-banner

Patients who are about to undergo planned therapy with a drug for which the summary of product characteristics strongly recommends genetic testing before treatment

top-banner

Patients who have to undergo long term therapy with known difficult-to-adjust medication (e.g., psychotropic drug therapy)

top-banner

Patients who suffer ADR or therapy resistance that are not due to drug/food interactions, allergies, etc.

OUR TESTS

If an ADR due to a genetic cause is suspected, genetic testing is recommended. Each patient should be considered individually since variants in different enzymes, transporters, or targets, can influence the efficacy of different drugs. There is no “one test fits all” drug tolerance test.

Recommended for patients with observed ADR or therapy resistance

A genetic testing analysis can be performed as a predictive test before an ADR is observed

Please note: current or planned medications should be listed on the order form, genes to be tested should be clearly stated on the order form (if not known, a consultation is offered – see below)

IndicationDrug
ANALGESICSMorphine prodrugs (CYP2D6), NSAIDs (CYP2C9)
ANESTHESIA INTOLERANCEMalignant hyperthermia (RYR1, CACNA1S), Postoperative apnea (BCHE)
CORONARY ARTERY DISEASE/METABOLIC SYNDROME/DIABETESβ-blockers (CYP2D6), Clopidogrel (CYP2C19), Statins (SLCO1B1), Sartans (CYP2C9), Sulfonylureas (CYP2C9), Warfarin/Phenprocuomon (CYP2C9, VKORC1)
INBORN ERRORS OF METABOLISMEliglustat – Gaucher disease (CYP2D6), Migalastat – Fabry disease (GLA), Tezacaftor/Ivacaftor/Elecacaftor – cystic fibrosis (CFTR)
MULTIPLE SCLEROSISSiponimod (CYP2C9)
ONCOLOGYAzathioprine (TPMT), Fluorouracil (DPYD), Irinotecan (UGT1A1), Paclitaxel (CYP2C8), Sacituzumab govitecan (UGT1A1), Tamoxifen (CYP2D6)
PSYCHOPHARMACOLOGYAntiepileptic drugs (CYP2C9), Dopamine (COMT), Multidrug resistance (ABCB1=MDR1), Psychotropic drugs (CYP2D6, CYP2C19, CYP3A5, CYP1A2, CYP3A4)
VIROLOGY/BACTERIOLOGYAbacavir (HLA-B), Efavirenz (CYP2B6), Peginterferon (IFNL3, ITPA), Sulfonamides (NAT2)

CONSULTATION

We offer pharmacogenetic testing since 2001. As the selection of a specific genetic test can be complex, we offer a detailed and free-of-charge pharmacogenetic consultation. This includes the examination of possible drug interactions in patients taking multiple medications or interpreting the results of therapeutic drug monitoring in the context of pharmacogenetic diagnostics. Thus, it is possible to determine which examinations are useful for clarifying the medical question before the test. In addition, a consultation can also be sought after receiving the results.

OUR PHARMACOGENETIC SERVICES

1

Counseling of physicians & patients

2

Drug metabolism & interaction check

3

Routine genetic testing & test development

4

Panel diagnostics for clinical studies

ORDER FORM
ACCEPTED MATERIAL

1-2 ml EDTA Blood
Since it is a genetic test, drug intake does not affect the test result. Preliminary testing (e.g. therapeutic drug monitoring) is desirable, but not mandatory.
Please note: DO NOT FREEZE. Ship with a frozen ice pack. Prepare the package such that the tube is tightly packed and not loose. Avoid getting the blood tube wet from the ice pack. Place a paper towel in between ice pack and blood tube if necessary. In sub-zero temperatures, include an unfrozen ice pack in the shipping container as insulation.

TURNAROUND TIME

Results available in 1-2 weeks from sample receipt

TECHNOLOGY

DNA is isolated and next generation sequencing is performed on all coding exons and conserved intronic regions. Single base pair changes, small deletions and duplications and copy number variants (CNV) are identified. Sequencing runs result in a Quality Score of >30 (accuracy >99.9%) in at least 75% of all bases with a coverage of >20-fold. CNV detection sensitivity is 76.99% and precision is 62.59% (with GC limitation between 0.4 and 0.6 per target sensitivity is 77.04% and precision is 84.10%). Variant classification is performed following ACMG guidelines (Richards et al. 2015, Genet Med 17:405; Kearney et al. 2011, Genet Med 13:680).

Test Methodology
Sequencing

Next generation
sequencing (Illumina)

Enrichment

Twist Human Core
Exome plus Ref Seq
Spikeln

SNV and CNV data anlaysis

Illumina DRAGEN
Bio-IT Platform

Data Evaluation

VarSeq by
GoldenHelix

Reference Genome

hg38, NCBI GR38

Quality Criteria

>30 (precision >99,9%)
in min. 75% of bases

SNV detection sensitivity

99.92-99.93%; confirmation of reported SNV with Sanger
sequencing, data analysis with
SeqPilot

Classification of variants

Richards et al. 2015, Genet Med
17:405; Ellard et al. “ACGS Best
Practice Guidelines for Variant
Classification 2020″

in silico algorithms

MaxEntScan,
SpliceSiteFinder-like,
REVEL

Databases

HGMD Professional
release, ClinVar,
gnomAD

LATEST ARTICLES

Have you ever wondered how jet-setting across the globe might affect your gut health? A recent study has dug into this intriguing question, revealing…

Read more

In June 2023, Medicover Genetics attended the 56th conference of the European Society of Human Genetics (ESHG) which took place in Glasgow, Scotland….

Read more

Vitamin D, also known as “the sunshine vitamin”, is a fat-soluble vitamin that helps the body absorb calcium and phosphate, which are essential f…

Read more

Every movement our body makes is controlled by a long, thin, tube-like structure called the “spinal cord”. The spinal cord is part of our nervous…

Read more

Genetic variant databases are vital for interpreting genetic variations in clinical settings and research. However, misclassified variants can create…

Read more

A recent article published by our team in the International Journal of Molecular Sciences [1], aimed to evaluate the prevalence, prognostic and predi…

Read more

A healthy, nutritious and well-balanced diet is always important for a person’s well-being, and it is even more so during pregnancy as the developi…

Read more

The sun is hot and you are sweating. Most of us know how it feels to sweat, and when we sweat. This is a normal bodily response to an increase in tem…

Read more

All about the pancreas The pancreas is a pear-shaped organ that is located at the upper left side of the abdomen, behind the stomach. It has two m…

Read more

The father of genetics is Gregor Mendel. Mendel was an Austrian monk, whose experiments breeding pea plants in the monastery garden led to breakthrou…

Read more

OUR NETWORK